Aidoc Partners With Nvidia to Establish Guideline to Accelerate AI Adoption in Healthcare

A New Framework to Enhance Integration and Scalability of AI Innovations Across Healthcare Systems.

Highlights

  • Aims to facilitate seamless integration and scalability of AI in healthcare.
  • Focus on interoperability, standardised validation, and real-world deployment.
  • Expected release in early 2025, marking an industry-first guideline.

Follow Us

Aidoc and Nvidia Partner to Launch AI Integration Guideline for Healthcare
Aidoc, a clinical AI company, has announced a partnership with Nvidia to co-develop the BRIDGE (Blueprint for Resilient Integration and Deployment of Guided Excellence) guideline, aimed at accelerating AI adoption across the healthcare industry. In what the companies call an industry-first guideline, set for release in early 2025, the evidence-driven framework will help healthcare systems seamlessly integrate and scale AI innovations more quickly.

Also Read: Microsoft Announces New AI Models and Solutions for Healthcare




BRIDGE Guideline

"The guideline will help establish clear pathways for healthcare systems to fully harness the potential of AI in improving patient outcomes," Aidoc said in a statement this week.

Aidoc notes that despite the approval of over 900 FDA-cleared AI tools, healthcare providers still struggle with fragmentation and scalability issues. BRIDGE will address these challenges by offering a comprehensive, vendor-neutral roadmap for AI deployment, focusing on scalability, interoperability, and continuous monitoring.

Addressing Fragmentation and Scalability Issues

According to the official release, the BRIDGE guideline will provide healthcare systems with guidance on addressing scalability and interoperability from the outset, enabling the simultaneous implementation of AI solutions across multiple sites.

"AI holds the potential to revolutionise patient care, but its progress has been stalled by fragmented systems and the inability to scale effectively," said Demetri Giannikopoulos, Chief Transformation Officer, Aidoc. "The BRIDGE guideline will focus on breaking down these barriers, offering a powerful, evidence-based framework that health systems can rely on not just adopt AI but to help scale it across their operations. This will drive both operational efficiency and significantly better outcomes for patients and clinicians alike."

Also Read: GE HealthCare Announces CareIntellect App for Oncology With AI-Powered Insights for Clinicians

Key Focus Areas of the BRIDGE Guideline

Key areas of focus include standardised validation, seamless integration of tools from different vendors, and a roadmap for scalable AI deployment across hospital systems. BRIDGE will also align with MONAI, an open-source platform co-founded by academia and industry in 2019, including Nvidia, to ensure standardisation and interoperability, the company said.

Aidoc added that BRIDGE will be specifically designed to help developers and healthcare providers consider the practicalities of real-world deployment. The guideline will be developed through close collaboration with healthcare providers, academic partners, and industry leaders.

Recent Comments

TheAndroidFreak :

Update: No hard cap on some of the prepaid sims. Reaching 180Mbps on 1-3-8 combination.

Airtel CEO Hints at New Structure for Mobile Tariffs to…

TheAndroidFreak :

Jio doesn't have 4CA at all in my opinion. Airtel won't have 4CA at all even after three years when…

Airtel CEO Hints at New Structure for Mobile Tariffs to…

Faraz :

Oh wow. This is pleasure to the eyes.. My smartphone has connected to 4 CA in Jio but for very…

Airtel CEO Hints at New Structure for Mobile Tariffs to…

TheAndroidFreak :

BSNL working great on VoLTE? What's the status of BSNL in Mumbai? Or is it MTNL who is going to…

Airtel CEO Hints at New Structure for Mobile Tariffs to…

TheAndroidFreak :

If you want overall best phone, then avoid Realme. Get iQOO 13.

Realme GT 7 Pro is Coming to India with Snapdragon…

Load More
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments